Evidence map›Paper›PMID 22038916›Full record

ArticleInfection and immunity2012

Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatus.

Melissa A Gessner, Jessica L Werner, Lauren M Lilly, Michael P Nelson, Allison E Metz, Chad W Dunaway, Yvonne R Chan, Wenjun Ouyang, Gordon D Brown, Casey T Weaver and 1 more

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 126 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. The C-type lectin receptor Dcir (Frontiers in immunology · 2025
    Article
  5. Article
  6. I don't know about you, but I'm feeling IL-22.Cytokine & growth factor reviews · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Transcriptional profiling of a fungal granuloma reveals a low metabolic activity ofFrontiers in cellular and infection microbiology · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Differential Proinflammatory Responses toJournal of fungi (Basel, Switzerland) · 2021
    Article
  18. Article
  19. Article
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Melissa A GessnerDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Jessica L Werner
Lauren M Lilly
Michael P Nelson
Allison E Metz
Chad W Dunaway
Yvonne R Chan
Wenjun Ouyang
Gordon D Brown
Casey T Weaver
Chad Steele
University of Alabama at Birmingham · USGenentechUniversity of Aberdeen · GBUniversity of Pittsburgh · US

Funding

Pulmonary defense against aspergillus fumigatus R01HL096702 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STEELE, CHAD · 2010 to 2013
$1.6M
Dectin-1 and Invasive Pulmonary AspergillosisR01AI068917 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STEELE, CHAD · 2009 to 2010
$732k
NHLBI NIH HHS HL096702NHLBI NIH HHS R01 HL096702NIAID NIH HHS AI068917NIAID NIH HHS R01 AI068917Wellcome Trust 086558
6 · The paper itself

Abstract

We have previously reported that mice deficient in the beta-glucan receptor Dectin-1 displayed increased susceptibility to Aspergillus fumigatus lung infection in the presence of lower interleukin 23 (IL-23) and IL-17A production in the lungs and have reported a role for IL-17A in lung defense. As IL-23 is also thought to control the production of IL-22, we examined the role of Dectin-1 in IL-22 production, as well as the role of IL-22 in innate host defense against A. fumigatus. Here, we show that Dectin-1-deficient mice demonstrated significantly reduced levels of IL-22 in the lungs early after A. fumigatus challenge. Culturing cells from enzymatic lung digests ex vivo further demonstrated Dectin-1-dependent IL-22 production. IL-22 production was additionally found to be independent of IL-1β, IL-6, or IL-18 but required IL-23. The addition of recombinant IL-23 augmented IL-22 production in wild-type (WT) lung cells and rescued IL-22 production by lung cells from Dectin-1-deficient mice. In vivo neutralization of IL-22 in the lungs of WT mice resulted in impaired A. fumigatus lung clearance. Moreover, mice deficient in IL-22 also demonstrated a higher lung fungal burden after A. fumigatus challenge in the presence of impaired IL-1α, tumor necrosis factor alpha (TNF-α), CCL3/MIP-1α, and CCL4/MIP-1β production and lower neutrophil recruitment, yet intact IL-17A production. We further show that lung lavage fluid collected from both A. fumigatus-challenged Dectin-1-deficient and IL-22-deficient mice had compromised anti-fungal activity against A. fumigatus in vitro. Although lipocalin 2 production was observed to be Dectin-1 and IL-22 dependent, lipocalin 2-deficient mice did not demonstrate impaired A. fumigatus clearance. Moreover, lung S100a8, S100a9, and Reg3g mRNA expression was not lower in either Dectin-1-deficient or IL-22-deficient mice. Collectively, our results indicate that early innate lung defense against A. fumigatus is mediated by Dectin-1-dependent IL-22 production.

Indexed as

AnimalsAspergillus fumigatusBronchoalveolar Lavage FluidCells, CulturedColony Count, MicrobialDectin-1Interleukin-22InterleukinsLectins, C-TypeLungMiceMice, Inbred C57BLMice, KnockoutNeutrophilsPulmonary AspergillosisDectin-1Interleukin-22InterleukinsLectins, C-Type

Identifiers

PMID22038916
PMCPMC3255669
OpenAlexW1992803997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.